Immunic, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.01 |
397.02 |
139.99 |
15.00 |
670.55 |
1,288.90 |
| Przychód Δ r/r |
0.00% |
3308400.00% |
-64.74% |
-89.29% |
4371.11% |
92.22% |
| Przychód (min) |
0.01 |
397.02 |
139.99 |
15.00 |
670.55 |
1,288.90 |
| Przychód (max) |
0.01 |
397.02 |
139.99 |
15.00 |
670.55 |
1,288.90 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-96.40 |
-69.13 |
-56.01 |
-52.15 |
91.49 |
139.58 |
| Zysk netto % |
-803300.00% |
-17.41% |
-40.01% |
-347.72% |
13.64% |
10.83% |
| EPS (średnia) |
-0.96 |
-0.69 |
-0.51 |
-0.53 |
0.91 |
1.39 |
| Liczba analityków (Przychody) |
5 |
4 |
6 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
6 |
5 |
5 |
3 |
1 |
1 |
| symbol |
IMUX |
IMUX |
IMUX |
IMUX |
IMUX |
IMUX |